We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+24.69%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$36.8B
AUM Growth
+$6.93B
Cap. Flow
+$319M
Cap. Flow %
0.87%
Top 10 Hldgs %
24.6%
Holding
1,716
New
94
Increased
570
Reduced
352
Closed
45

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$84.4M
2
D icon
Dominion Energy
D
+$78.9M
3
LHX icon
L3Harris
LHX
+$78.2M
4
TFC icon
Truist Financial
TFC
+$65.8M
5
CB icon
Chubb
CB
+$61.3M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$132M
2
CME icon
CME Group
CME
+$131M
3
INTC icon
Intel
INTC
+$128M
4
JNJ icon
Johnson & Johnson
JNJ
+$117M
5
SHOP icon
Shopify
SHOP
+$97.1M

Sector Composition

Rank Sector Weight
1 Technology 22.74%
2 Healthcare 16.26%
3 Financials 13.14%
4 Consumer Discretionary 10.39%
5 Industrials 8.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIDD icon
1551
Middleby
MIDD
$5.98B
$264K ﹤0.01%
+3,350
New +$217K
BCEL
1552
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$264K ﹤0.01%
+12,401
New +$219K
HAFC icon
1553
Hanmi Financial
HAFC
$938M
$262K ﹤0.01%
27,000
MTSC
1554
DELISTED
MTS Systems Corp
MTSC
$262K ﹤0.01%
14,868
IMO icon
1555
Imperial Oil
IMO
$62.1B
$258K ﹤0.01%
15,335
+233
+2% +$3.5K
TNDM icon
1556
Tandem Diabetes Care
TNDM
$1.24B
$256K ﹤0.01%
2,585
SENEA icon
1557
Seneca Foods Class A
SENEA
$1.15B
$255K ﹤0.01%
7,533
AUPH icon
1558
Aurinia Pharmaceuticals
AUPH
$1.93B
$254K ﹤0.01%
+15,653
New +$251K
COLM icon
1559
Columbia Sportswear
COLM
$3.23B
$250K ﹤0.01%
3,100
-36,124
-92% -$2.63M
OFIX icon
1560
Orthofix Medical
OFIX
$489M
$250K ﹤0.01%
7,800
TPTX
1561
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$249K ﹤0.01%
+3,857
New +$223K
GHL
1562
DELISTED
Greenhill & Co., Inc.
GHL
$245K ﹤0.01%
24,505
HALO icon
1563
Halozyme
HALO
$9.84B
$239K ﹤0.01%
8,923
CATO icon
1564
Cato Corp
CATO
$67.1M
$233K ﹤0.01%
28,428
SITC icon
1565
SITE Centers
SITC
$234M
$228K ﹤0.01%
36,059
-1,962,382
-98% -$9.61M
TFIN icon
1566
Triumph Financial Inc
TFIN
$1.83B
$228K ﹤0.01%
9,400
ARQT icon
1567
Arcutis Biotherapeutics
ARQT
$3.49B
$227K ﹤0.01%
7,500
GEOS icon
1568
Geospace Technologies
GEOS
$84.2M
$227K ﹤0.01%
30,135
+5,800
+24% +$38.6K
VIR icon
1569
Vir Biotechnology
VIR
$1.46B
$227K ﹤0.01%
+5,550
New +$186K
SPB icon
1570
Spectrum Brands
SPB
$2.03B
$225K ﹤0.01%
+4,910
New +$208K
KNSA icon
1571
Kiniksa Pharmaceuticals
KNSA
$6.18B
$213K ﹤0.01%
+8,352
New +$174K
ECHO
1572
EchoStar
ECHO
$24.5B
$212K ﹤0.01%
+7,570
New +$230K
CSR
1573
Centerspace
CSR
$945M
$211K ﹤0.01%
3,000
SUI icon
1574
Sun Communities
SUI
$15.6B
$209K ﹤0.01%
+1,540
New +$204K
BKI
1575
DELISTED
Black Knight, Inc. Common Stock
BKI
$209K ﹤0.01%
+2,880
New +$204K

Similar funds

Ensign Peak Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Ensign Peak Advisors held 1,716 positions worth $36.8B, up 23% from $29.9B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ensign Peak Advisors's Q2 2020 filing shows 94 new, 570 increased, 352 reduced and 45 closed positions. Its largest new stake was Carrier Global: 992,630 shares worth $22.1M. The largest sale was Apple, an estimated $132M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q2 2020 buy was Carrier Global: 992,630 shares worth $22.1M.
  • Ensign Peak Advisors added most to Eli Lilly in Q2 2020, an estimated $84.4M increase.
  • Ensign Peak Advisors's biggest Q2 2020 reduction was Apple, cutting an estimated $132M.
  • Ensign Peak Advisors fully exited VOCERA COMMUNICATIONS, INC. in Q2 2020, selling an estimated $9.21M.
  • Ensign Peak Advisors's ten largest holdings make up 25% of its $36.8B portfolio in Q2 2020.
  • Ensign Peak Advisors opened 94 new positions and closed 45 in Q2 2020.
  • Ensign Peak Advisors's portfolio value rose 23% quarter-over-quarter to $36.8B.

Based on Ensign Peak Advisors's 13F filing for Q2 2020, filed 12 Aug 2020.